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ABSTRACT 
 
Introduction 
Functional outcome following surgical repair in brachial plexus avulsion injury 
remains poor.  Spinal motorneuron death after brachial plexus avulsion injury has 
been identified as the neurobiological barrier to functional restitution.  Post injury 
oxidative stress reaction, for example, up-regulation of neuronal nitric oxide synthase 
(nNOS), not only cause direct damage to the motoneurons, but lead to mitochondrial 
dysfunction as well, especially the cytochrome c oxidase (CcO) activity, which serve 
as the main energy generator for neuronal normal activities.  Furthermore, the 
impaired retrograde axonal transport of neurotrophic factors (which are vital for 
motoneurons survival) secondary to neurofibrogenesis and mitochondrial 
dysfunction has retarded the neuronal regeneration process.  Taxol, a diterpene 
alkaloid, has the effect in slowing the neurofibrogenesis by microtubule stabilization 
and facilitate axonal regeneration in rats.  This study was designed to evaluate the 
neuroprotective effect of intrathecally infused Taxol in the prevention of motoneuron 
death and mitochondrial dysfunction following brachial plexus avulsion injury.  
 
Material and Method 
Sprague-Dawley rats were divided into Treatment and Control groups (each group 
N=32).  Brachial root avulsion injury was induced in each rat.  The Treatment group 
received 5 days intrathecal infusion of Taxol (256ng/day) via a micro infusion pump, 
whereas the Control group received normal saline.  Cervical cord was harvested at 
survival interval of 1 week, 2 weeks, 4 weeks and 6 weeks (n=8 in each subgroup).  
Number of surviving motoneurons and nNOS-positive motoneurons at injured 
xi 
 
ventral horn were determined with NADPH-d histochemistry with neutral red 
counterstaining.  Mitochondrial function at the injured ventral horn was measured 
with CcO histochemistry and densitometer.  Independent t-test was applied to detect 
differences between the study groups at specific survival interval.  
 
Results  
Compared to Control group, the Taxol treated group showed significant reduction in 
the nNOS expression at 2 weeks, 4 weeks, and 6 weeks, and significantly improved 
mitochondrial functions at 4 weeks and 6 weeks.  The motoneurons survival rate was 
significantly increased at 2 weeks, 4 weeks, and 6 weeks in Taxol treated rats.  
 
Conclusions 
Taxol has the neuroprotective effect to prevent spinal motoneuron degenaration 
following brachial plexus avulsion injury by inhibiting nNOS expression and 
preventing mitochondrial dysfunction.   
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ABSTRAK 
 
Pengenalan 
Pemulihan fungsi berikutan pembedahan perbaikan untuk kecederaan avulsi brachial 
plexus masih kurang memuaskan.  Kematian pada motoneuron saraf tunjang selepas 
kecederaan avulsi brachial plexus telah dikenalpasti sebagai halangan utama dalam 
pemulihan fungsi.  Reaksi tekanan oksidatif selepas kecederaan, sebagai contoh, 
kenaikan regulasi neuronal nitric oxide synthase (nNOS), bukan sahaja telah 
merosakkan motoneuron, malah ia juga menyebabkan ketidakfungsian mitokondria, 
terutama sekali aktiviti cytochrome c oxidase (CcO), yang merupakan penghasil 
tenaga utama untuk aktiviti-aktiviti normal neuron.  Selain itu, kegagalan 
pengangkutan axonal songsang untuk faktor-faktor neutrofik (yang amat penting 
untuk kehidupan motoneuron) akibat daripada neurofibrogenesis dan ketidakfungsian 
mitokondria telah membantutkan proses regenerasi neuron.  Taxol, sejenis alkaloid  
diterpene, telah didapati mempunyai kesan untuk melambatkan neurofibrogenesis 
melalui penstabilan mikrotubul dan mendorong regenerasi axon.  Kajian ini telah 
dirancang untuk menentukan kesan pelindung-saraf Taxol secara infusi intrathecal 
dalam membendungi kematian motoneuron dan ketidakfungsian mitokondria selepas 
kecederaan avulsi brachial plexus.    
 
Bahan dan Kaedah 
Tikus Sprague-Dawley telah dibahagikan kepada dua kumpulan utama, Rawatan dan 
Kontrol (setiap kumpulan utama N=32).  Kecederaan avulsi pada akar saraf brachial 
telah ddilaksanakan ke atas setiap tikus.  Kumpulan Rawatan telah menerima infusi 
Taxol secara intrathecal selama 5 hari (256ng/hari) melalui pump infusi mikro, 
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sedangkan kumpulan Kontrol telah menerima saline biasa.  Saraf tunjang cervikal 
telah dikeluarkan pada 1, 2, 4 dan 6 minggu selepas kecederaan (setiap kumpulan 
kecil n=8).  Bilangan motoneuron hidup dan motoneuron nNOS-positif pada ventral 
horn yang cedera telah ditentukan dengan histokimia NADPH-d dan penwarnaan 
neutral red.  Fungsi mitokondria pada ventral horn yang cedera telah ditentukan 
dengan histokimia CcO dan densitometer.  Independent t-test telah digunakan untuk 
mengesan perbezaan di antara kumpulan-kumpulan kajian pada jangkamasa tertentu 
selepas kecederaan.  
 
Keputusan  
Berbanding dengan kumpulan Kontrol, kumpulan Rawatan telah menunjukkan 
penurunan signifikan dalam ekspresi nNOS 2 pada minggu 2, 4, dan 6 selepas 
kecederaan, serta kenaikan signifikan fungsi mitokondria pada minggu 4 dan 6 
selepas kecederaan.  Kadar kehidupan motoneuron juga meningkat secara signifikan 
pada minggu 2, 4, dan 6 selepas kecederaan untuk tikus-tikus yang menerima 
rawatan Taxol.  
 
Kesimpulan 
Taxol didapati mempunyai kesan pelindung-saraf untuk membendung degenerasi 
motoneuron saraf tunjang berikutan kecederaan avulsi brachial plexus secara 
perencatan ekspresi nNOS dan mengelakkan ketidakfungsian mitokondria. 
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CHAPTER 1:  INTRODUCTION 
 
Brachial plexus injuries in adults are commonly caused by motor-vehicle accidents 
or self-accidents such as fall from height.  The surgical management of brachial 
plexus injury consists of nerve repair and nerve grafting for extraforaminal nerve 
root or trunk injury, and neurotization or nerve transfer for nerve root avulsion injury 
(Songcharoen, 2008).  However, the outcome of brachial plexus reconstruction and 
the restoration of shoulder and elbow function are often poor in spite of the 
sophistication of the various methods used (Blaauw et al., 2008; Songcharoen, 2008). 
 
The degeneration and death of a major proportion of the innervating neuronal pool is 
likely to be the most fundamental neurobiological barrier to functional restitution 
because survival is an essential prerequisite for regeneration (De Palma et al., 2008).    
Root avulsion of the brachial plexus causes an oxidative stress reaction in the spinal 
cord and induces gradual spinal motoneuron death.  Loss of neurotrophic factors 
support secondary to axonal transport failure also leads to spinal motoneuron death 
as well (Yin et al., 2008).  After brachial root avulsion in rats, about 20% of the 
spinal motoneurons died at 2 weeks after the injury and about 50% of them were lost 
at 4 weeks after the injury (Wang et al., 2010). 
 
Animal studies showed de novo expression of neuronal nitric oxide synthase (nNOS) 
in injured spinal motoneurons.  The time course and density of nNOS expression 
were correlated with the severity of spinal motoneuron death following brachial root 
avulsion injury, in which the oxidant peroxynitrite (ONOO¯) played an important 
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role.  Maximum expression of nNOS in the injured spinal motoneurons was observed 
between 2-3 weeks following avulsion injury (Yang et al., 2008). 
 
After spinal root avulsion injury, the neurotrophic factors (brain-derived 
neurotrophic factor, BDNF, and glial cell-derived neurotrophic factor, GDNF) are 
released from the innervated target site, taken up by the nerve terminal, and 
transported to the cell body via retrograde axonal transport.  These factors are 
important for axonal regeneration and survival of the injured spinal motoneurons 
(Sendtner and Beck, 2009).  However, scarring and fibrosis of the injured nervous 
tissue may impair axonal regeneration and eventually affect the neurotrophic factors 
transportation along the axon (Hellal et al., 2011) and lead to the motoneurons death 
subsequently. 
 
In addition, exposure to nitric oxide (NO) and reactive oxygen species (ROS) 
following post-traumatic inflammatory process would lead to neuronal mitochondrial 
dysfunction, especially the complex IV (cytochrome c oxidase) activity which serves 
as the main source for neuronal energy production (Mahad et al., 2009).  Thus, 
deprivation of both motoneurons energy demands and interference of the 
neurotrophic factors retrograde axonal transport to the cell bodies have reduced the 
survival rate of spinal motoneurons following the brachial plexus avulsion injury. 
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CHAPTER 2:  LITERATURE REVIEW 
 
2.1  The Anatomy of Brachial Plexus in Rats 
 
Most of the experimental studies on spinal cord and peripheral nerve injuries were 
using rats sample.  Although there was a clear homology with the elements of the 
brachial plexus in the rat and in man, the origin of the different terminal and 
collateral branches were found to be different in these two species (Pais et al., 2010).  
The rat the spinal cord is made up of 34 segments: 8 cervical (named C1 to C8), 13 
thoracic (T1 to T13), 6 lumbar (L1 to L6), 4 sacral (S1 to S4), and 3 coccygeal (Co1 
to Co3).  A brachial plexus morphology study in 30 rats by Angelica-Almeida et al. 
(2013) demonstrated that brachial plexus was composed of branches originating from 
the ventral aspect of C4 to C8 and T1.  In 57% of cases, the ventral aspect of T2 
established an anastomosis with the ventral aspect of T1, thus contributing to the 
formation of the brachial plexus.  This branch from T2, as well as the branch from 
C4 to the brachial plexus, was smaller than the remaining branches that formed the 
roots of the plexus.  The brachial plexus roots emerged between the anterior and 
middle scalene muscles, forming a flattened plexus below the clavicle.  The lateral, 
medial and posterior cords of the plexus were not clearly seen compared to those in 
human.  The median nerve was the thickest terminal branch of the brachial plexus in 
rats, and almost always originated from three different roots.  A branch from the 
second and/or the third intercostal nerve to the medial brachial and medial 
antebrachial cutaneous nerves was found in 87% of cases.  Figure 2.1 shows the 
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schematic diagram of the anatomy of brachial plexus in rat.  Plate 2.1 shows the 
branches of brachial plexus in rat and their association with the major arterial trunks. 
 
 
Figure 2.1:  Schematic diagram of the brachial plexus in rat  
(Source:  Angelica-Almeida et al.,2013) 
1- Axillary nerve; 2- Musculocutaneous nerve; 3- Radial nerve; 4- Median nerve; 5- 
Ulnar nerve; 6- Medial brachial cutaneous nerve; 7- Medial antebrachial cutaneous 
nerve; 8- Dorsal scapular nerve; 9- Suprascapular nerve; 10- Nerve to subclavius 
muscle; 11- Upper subscapular nerve; 12- Lower subscapular nerve; 13- 
Thoracodorsal nerve; 14- Long thoracic nerve; 15- Lateral pectoral nerve; 16- Medial 
pectoral nerve. 
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Plate 2.1:  Brachial plexus and the arterial supply in rat 
(Source:  Angelica-Almeida et al.,2013) 
Ventral aspect of a right forepaw dissection showing several of the terminal and 
collateral branches of the brachial plexus, and their association with several major 
arterial trunks (4X magnification).  1- Axillary nerve; 2- Musculocutaneous nerve; 3- 
Radial nerve; 4- Median nerve; 5- Ulnar nerve; 6- Medial brachial cutaneous nerve; 
8- Dorsal scapular nerve; 9- Suprascapular nerve; 10- Nerve to subclavius muscle; 
11- Upper subscapular nerve; 12- Lower subscapular nerve; 15- Lateral pectoral 
nerve; 16- Medial pectoral nerve; 18- Axillary artery; 19- Brachial artery; 20- 
Acromial arterial trunk. 
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The arterial supply to the BP plexus was seen to derive directly or indirectly from the 
vertebral, axillary, brachial, and median arteries, as well as from arteries arising 
directly from the aortic arch, and from the acromial and cervical arterial trunks.  The 
venous drainage followed a similar path to the homonymous arterial structures, 
draining ultimately in the median, brachial, axillary and cephalic veins 
 
2.2  The Anatomy of Ventral Roots, Dorsal Roots and Spinal Cord-Spinal Nerve 
Junction in Rats 
 
The spinal cord is divided into spinal cord segments.  Each segment gives rise to 
paired spinal nerves.  Ventral and dorsal spinal roots arise as a series of rootlets 
(Plate 2.2).  A spinal ganglion is present distally on each dorsal root.  Each ventral 
root (also named the anterior root, radix anterior, radix ventralis, or radix motoria) is 
attached to the spinal cord by a series of rootles that emerge from the ventrolateral 
sulcus of the spinal cord.  Unlike the dorsal root fibers that are arranged in a neat line 
at their emergence from the spinal cord, ventral root fibers form an elliptical area 
named the anterior root exit zone (AREZ).  The ventral roots predominantly consist 
of efferent somatic motor fibers (thick alpha motor axons and medium-sized gamma 
motor axons derived from nerve cells of the ventral column (Watson et al., 2009).  
Each dorsal root (also known as the posterior root, radix posterior, radis dorsalis or 
radiz sensoria) is attached to the dorsolateral sulcus of the spinal cord by a series of 
rootlets arranged in a line, the dorsal root entry zone (DREZ).  In the experimental 
study using rat model, the avulsion surgery was done by separating both the ventral 
and dorsal roots at the junction between their attachment to the spinal cord, which 
were the AREZ and DREZ (Watson et al., 2009).   
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Plate 2.2:  Dorsal and ventral roots of spinal nerves 
(Source:  Watson et al., 2009) 
This is a dissection showing the ventral surface of the spinal cord and the ventral and 
dorsal rootlets.  Groups of rootlets form the dorsal and ventral roots of each spinal 
nerve.  The dura and arachnoid have been removed to expose the spinal cord.  The 
junction between spinal cord and ventral root (anterior root exit zone, AREZ) is 
labeled **. 
 
 
 
 
 
 
 
 
 
*
* 
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The spinal cord gray matter is made up of neuronal cell bodies, dendrites, axons, and 
glial cells.  The neurons are mostly multipolar, but vary greatly in size.  Microscopic 
analysis of the spinal gray matter reveals ten different cytoarchitecture layers of cells 
from dorsal to ventral, which are the laminae of Rexed.  Lamina IX, located at the 
base of the ventral horn, is the site of the motoneurons of the spinal cord (Plate 2.3).  
The α-motoneurons, whose axons innervate striated muscles, are the largest of all 
cells in the spinal cord and are usually star-shaped.  Amongst these large cells, some 
small γ-motoneurons which innervate contractile elements of the muscle spindles are 
also found (Watson et al., 2009). 
 
 
Plate 2.3:  Histological section across C7 spinal segment in rat 
(Source:  Watson et al., 2009) 
The red circle indicates the location of lamina IX.  The blue circle indicates the 
anterior root exit zone, AREZ. 
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2.3  Brachial Plexus Injury 
 
Brachial plexus injury (BPI) is a severe neurologic injury that causes significant 
functional impairment of the affected upper limb.  The most common cause of BPI is 
road traffic accidents with most of the victims being young males (Shin et al., 2010; 
Songcharoen, 2008).  Other reported traumatic causes include sport injuries, 
accidents at work, penetrating injuries, gunshot wounds, and iatrogenic causes (for 
example, patient malpositioning during surgery).  Another common cause of BPI is 
birth palsy (Shin et al., 2010).  The majority of obstetric BPI involves the upper 
brachial plexus, for example the Erb or Duchenne palsy.  Lower type obstetric BPI 
(Klumpke palsy) is rare.  Tumors, irradiation, and congenital abnormalities such as 
cervical ribs can be nontraumatic causes of brachial plexopathy. 
 
BPI is caused by severe traction force exerted on the upper limb, resulting in 
complete or partial motor paralysis.  An upper brachial plexus lesion involves spinal 
nerves C5 and C6 and leads to paralysis of the shoulder muscles and biceps.  When 
the damage extends to spinal nerve C7, some of the wrist muscles are also impaired.  
A lower brachial plexus lesion involves spinal nerves C8 and T1 leads to paralysis of 
the forearm flexor and the intrinsic muscles of the hand (Cardenas-Mejia et al., 
2008).   
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2.3.1  Classification of Brachial Plexus Injury 
 
Adult BPI remains a dilemma to many surgeons, especially when planning to 
reconstruct cases of total root avulsion.  Different degrees and different levels of 
injury require different approaches of reconstruction.  Chuang (2010) classified 
brachial plexus injury into 4 levels as shown in Table 2.3.1. 
 
Table 2.3.1:  Chuang’s classification of brachial plexus injury 
Type of Injury Description 
Level 1 Preganglionic root injury including spinal cord, rootlets, and root 
injuries. 
 
Level 2 Postganglionic spinal nerve injury limiting the lesion to the 
interscalene space and proximal to the suprascapular nerve. 
 
Level 3 Preclavicular and retroclavicular BPI including trunks and 
divisions. 
 
Level 4 Infraclavicular BPI including cords and terminal branches 
proximal to the axillary fossa. 
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2.3.2  Management of Brachial Plexus Injury 
 
Factors that would determine the choices of treatment in BPI include: i) the degree of 
damage, ii) the site of injury, iii) the number of roots involved, iv) the time interval 
between the injury and the surgical procedure, and V) the patient‟s age and 
occupation.  Among these, the degree of damage and the site of injury are the most 
important factors (Doi, 2008).  Management of BPI can be either conservative or 
surgical.  Representative surgical procedures include neurolysis, nerve grafting, 
nerve transfer, and other reconstructive procedures involving the transplantation of 
various structures (Cardenas-Mejia et al., 2008; Doi, 2008).   
 
Preganglionic injuries are usually considered not amenable to repair; consequently, 
the functions of some denervated muscles are restored with nerve transfers.  In nerve 
transfer, the donor nerve is attached to the ruptured distal stump, sacrificing the 
original function of the nerve for more beneficial functions in the upper limb 
(Rankine, 2010).  It is generally agreed that the top priority of nerve repair is 
restoration of biceps muscle function and the second goal is reanimation of shoulder 
function (Chuang, 2010; Doi 2008).  Intercostal nerve is frequently used as the donor 
nerve transferred to the musculocutaneous nerve to regain elbow flexion.  Functional 
recovery of the shoulder is largely achieved with transfer of spinal accessory nerve to 
the suprascapular nerve.  Feng et al. (2010) reported nerve transfer of contralateral 
C7 to lower trunk via a subcutaneous tunnel across the anterior surface of chest and 
neck in 4 patients with total brachial plexus avulsion and the procedure was proved 
to be a safe and feasible.  Compared with the traditional transfer of the contralateral 
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C7 to the median nerve, it might help patients gain better restoration of wrist flexion, 
finger flexion, and hand sensation. 
 
In postganglionic injury with disruption of the nerve fibre, it is repaired with nerve 
grafting.  The damaged segment is excised and nerve autograft is placed between the 
two nerve ends (Chuang, 2010).  If the postganglionic lesion in continuity is non-
degenerative or the fascicles are still intact, spontaneous recovery is usually expected 
with conservative management.  Whereas postganglionic lesion in continuity of 
degenerative type with damaged fascicles, it is treated with nerve grafting.  Patient 
with severe BPI should undergo an appropriate reconstructive procedure before 
denervated muscles become irreversibly atrophy, otherwise the patient will no longer 
a good candidate for primary nerve repair (Rovak and Tung, 2009). 
 
2.3.3  Surgical Outcome in Brachial Plexus Avulsion Injury 
 
Avulsion of brachial roots from the spinal cord is a devastating injury with a bleak 
prognosis.  Patients with preganglionic type of BPI have been reported with poorer 
surgical outcome (Rovak and Tung, 2009; Terzis et al., 2009).  Experimental studies 
with implantation of avulsed ventral roots in rats, cat, and chimpanzee were shown to 
promote motor recovery.  This is because axons from spinal cord motoneurons can 
grow into ventral roots and peripheral nerves (Yang et al., 2008).  However, the 
clinical usefulness of reimplantation in patient with brachial roots avulsion is not 
clear.  The current practice of surgical repair of brachial plexus avulsion by 
reimplantation of avulsed roots via a peripheral nerve graft provides a small degree 
of motor recovery; however, useful hand function is mostly not restored in adult 
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patients.  There is no recovery of sensation, although pain is usually alleviated for the 
reimplanted segments (Rankine, 2010). 
 
2.4 Molecular Pathogenesis of Post Traumatic Spinal Motoneurons 
Degeneration  
 
Much of the spinal tissue degeneration that occurs following spinal cord injury (SCI) 
is due to secondary injury processes that are triggered by the primary mechanical 
trauma.  The events of the secondary injury phase can be divided into early and 
delayed stages (Kuzhandaivvel et al., 2011; Donnelly and Popovich, 2008).  The 
early stage of secondary injury is thought to start with excitotoxic damage due to 
massive release of glutamate together with a pathological cascade comprising nitric 
oxide, free oxygen radicals, and metabolic dysfunction due to ischemia/hypoxia, 
energy store collapse, acidosis, and edema triggered by loss of vascular tone 
autoregulation.  Later, macrophage infiltration and initiation of glial scar occur 
(Hagg and Oudega, 2008; Donnelly and Popovich, 2008).   
 
This early stage of secondary injury starts minutes after primary insult and can lasts 
up to weeks after injury.  Extracellular glutamate levels are known to increase 
transiently within the first 3 hours after SCI, with a likely second wave of glutamate 
release 2 to 3 days after injury, probably due to delayed myelin destruction that 
compromises nearby axon integrity.  The over-stimulation of glutamate receptors has 
been reported to contribute to neuronal and glial cell death after experimental SCI 
(Hagg and Oudega, 2008).     
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The delayed stage of secondary injury starts 2 weeks to 6 months after the insult, 
glial scarring continues together with intraspinal cyst formation.  Even later, 
profound pathological changes affect spinal networks through Wallerian 
degeneration, demyelination, and aberrant plasticity with circuit rewiring leading to 
dysfunction like chronic pain and spasticity (Kuzhandaivel et al., 2011; Donnelly and 
Popovich, 2008). 
 
2.4.1  Nitric Oxide Synthase 
 
Nitric oxide (NO) is a gaseous neurotransmitter in central nervous system (CNS) and 
peripheral nervous system (PNS), and is able to diffuse across the cell membrane.  
NO is involved in several physiological processes including smooth muscle 
relaxation, inflammation, vasodilatation, neurogenesis, synaptic plasticity, long-term 
potentiation, and nociceptive transmission (Freire et al., 2009).  Low levels of NO 
production are important in prevention of cells apoptosis.  However, elevated levels 
secondary to increased NO production result in direct cytotoxicity (De Palma et al., 
2008).  Reaction between this NO and superoxide radicals (O2
-
) will produce a type 
of reactive oxidative species (ROS) called peroxynitrite (PN).  PN has been proposed 
to be a key contributor to post-traumatic oxidative damage, mainly because of its 
highly reactive decomposition products nitrogen dioxide (
·
NO2), hydroxyl radical 
(
·
OH) and carbonate radical (CO3
·−
).  These PN-derived radicals can oxidize proteins 
and nitrate tyrosine residues, induce cell membrane lipid peroxidation, cause single-
strand DNA breaks, and also inhibit mitochondrial respiration (Alvarez and Radi, 
2009). 
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The enzyme nitric oxide synthase (NOS) catalyzes the production of nitric oxide 
from L-arginine and oxygen, and different isoforms of the enzyme exist in different 
tissues.  NO is constitutively produced by neuronal NOS (nNOS) and endothelial 
NOS (eNOS) in a calcium-dependent manner, and is also formed by an inducible 
form of the enzyme (iNOS), which may have detrimental effects on the cell 
(Miclescu and Gordh, 2009).  Neuronal NOS is found in both the CNS and PNS.  
Neuronal NOS has been specifically localized to spinal cord dorsal horn neurons and 
dorsal root ganglia cells, and is upregulated in conditions of inflammatory and 
neurogenic pain (Schmidtko et al., 2009). 
 
Peripheral nerve lesions and spinal cord injury have been shown to induce 
upregulation of all NOS isoforms, as demonstrated by NADPH-diaphorase 
histochemistry.  Such increases in NOS expression result in enhanced expression of 
NO in the nerve microenvironment and induce mitochondrial dysfunction as well as 
neuronal cells death (Yang et al., 2008).   
 
2.4.2  Free Radical-Induced Lipid Peroxidation 
 
Extensive evidence has shown that free radical-induced lipid peroxidation (LP) plays 
a major role in the acute pathophysiology of SCI (Alvarez and Radi, 2009).  LP 
begins with the oxidation of polyunsaturated fatty acids (e.g., arachidonic, linoleic, 
and docosahexaenoic acids) in the cell, or in membrane phospholipids at their allylic 
carbon.  The peroxidized polyunsaturated fatty acids undergo phospholipase-
mediated hydrolysis and consequent disruption of the membrane phospholipid 
architecture, and loss of the function of phospholipid-dependent enzymes, ion 
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channels, and structural proteins.  However, in addition to LP-induced membrane 
damage, the peroxidized fatty acids ultimately give rise to aldehydic breakdown 
products, including 4-hydroxy-2-nonenal (4-HNE) and 2- propenal (acrolein).  These 
aldehydes are highly reactive with cellular proteins via Schiff base and Michael 
addiction reactions with basic (for example, lysine and histidine) and sulfhydryl (for 
example, cysteine) containing amino acids (Stevens and Maier, 2008). These 
reactions have been shown to impair the function of a variety of cellular proteins, 
which could also contribute to post-traumatic secondary injury and the associated 
pathophysiology.  Sources of post-traumatic reactive oxygen species (ROS) that 
result in toxic LP-inducing secondary injury include iron-dependent Fenton 
reactions, which result in hydroxyl radical (·OH) production and peroxynitrite 
(PON)-derived free radicals (·OH, ·NO2, and ·CO3) 
 
2.5  Mitochondrial Oxidative Phosphorylation Activity 
 
The predominant physiological function of mitochondria is the generation of ATP by 
oxidative phosphorylation.  Additional functions include the generation and 
detoxification of reactive oxygen species, involvement in some forms of apoptosis, 
regulation of cytoplasmic and mitochondrial matrix calcium, synthesis and 
catabolism of metabolites and the transport of the organelles themselves to correct 
locations within the cell (Ramzan et al., 2010).  
 
Almost all functions of mitochondria are either directly or indirectly linked to the 
working of oxidative phosphorylation machinery and energy coupling.  Most part of 
this machinery is in the inner mitochondrial membrane and comprises the four 
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electron transfer chain complexes (complexes I, II, III, and IV), ATP synthase 
(complex V), NADH dehydrogenase (ubiquinone), and cytochrome c as electron 
carriers (Magrane and Manfredi, 2009; Brand and Nicholls, 2011).  Complex IV or 
cytochrome c oxidase (CcO) is the terminal enzyme of the electron transport chain, 
which catalyzes the final step of electron transfer from reduced cytochrome c to 
oxygen to produce water (H2O).  CcO is also one of the three proton pumps along 
with complexes I and III that generate the proton gradient across the inner 
mitochondrial membrane, which powers the ATP synthesis.  A very common 
approach to address mitochondrial bioenergetics dysfunction is to measure the 
expression, concentration or maximum activity of a few candidate electron transport 
complexes or metabolic enzymes, such as complex I and complex IV (Acin-Perez et 
al., 2011; Brand and Nicholls, 2011). 
 
2.5.1  Cytochrome c Oxidase 
 
CcO in mammals contains 13 subunits of which the 3 catalytic subunits are encoded 
by the mitochondrial genes.  The remaining 10 subunits, which are synthesized in 
cytosol and imported into mitochondria, are coded by the nuclear genome.  These 
subunits are believed to provide structural stability to the complex as well as 
involved in the regulation of enzyme activity.  CcO contains two heme groups (heme 
a and a3) and two copper centers (Cu
2+
 A and Cu
2+
 B) as catalytic centers and 
handles more than 90% of molecular O2 respired by the mammalian cells and 
tissues.  CcO acts as the rate-limiting step of the respiratory chain and its activity is 
an indicator of the oxidative capacity of the cells (Acin-Perez et al., 2011). 
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2.5.2  Mitochondrial Transportation 
 
Mitochondrial function, including aerobic production of ATP and calcium buffering, 
is vital to the health of the neuron, and therefore neurons must have a proper 
intracellular distribution of mitochondria.  Mitochondria are enriched at sites of high 
ATP utilization and Ca
2+
-buffering demands, such as cell bodies, nodes of Ranvier, 
and synaptic terminals (Reeve et al., 2008).  Mitochondria are actively transported to 
areas of high metabolic demand by the motors kinesin and dynein in a calcium 
regulated process involving the protein Milton and the mitochondrial Rho GTPase.  
In addition, mitochondria are also transported along the cell processes in variable 
speed with intracellular signalling (Magrane and Manfredi, 2009).  The direction of 
mitochondrial transport has been proposed to correlate with their bioenergetics state: 
mitochondria with normal membrane potential tend to move toward the periphery 
(anterograde movement), whereas loss of membrane potential results in increased 
retrograde transport (Srinivasan and Avadhani, 2012).  Defects in mitochondrial 
transport would lead to altered distribution of mitochondria along the axon, in turn 
leading to an inability to meet local ATP demands and/or toxic changes in calcium 
buffering. 
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2.5.3  Mitochondrial Dysfunction 
 
The mitochondria are present in a physiological environment, are exposed to a 
relevant mix of substrates and ions and interact with the cytoplasm, plasma 
membrane and other organelles and cell structures.  The structure and function of the 
enzyme are affected in a wide variety of diseases including cancer, 
neurodegenerative diseases, myocardial ischemia or reperfusion, bone and skeletal 
diseases, and diabetes (Cooper and Brown, 2008).  Except in cases of genetic defects, 
it is commonly seen that mitochondrial dysfunction is a cumulative effect of failure 
of more than one complex of the electron transport chain (Mahad et al., 2009).  Some 
of the common mechanisms of CcO dysfunction include assembly defects, covalent 
modifications and loss of subunits, disassembly of super complex organization and 
direct inhibition of enzyme activity.  The impact of these events includes energy 
crisis due to lower ATP production, lactic acidosis, and increased formation of ROS 
in mitochondria (Ramzan et al., 2010). 
 
Four different gases, nitric oxide (NO), carbon monoxide (CO), hydrogen sulfide 
(H2S), and hydrogen cyanide bind to CcO and invariably inhibit the enzyme activity.  
NO has been established as an important second messenger, which is involved in 
diverse physiological and pathological functions.  Although soluble guanyl 
atecyclase is one of its most prominent targets, NO interacts with metal centers of 
many proteins.  The inhibition of CcO by NO is thought to be reversible.  Since O2 
and NO compete for the same binding site in CcO, endogenously generated NO can 
reach concentrations that are inhibitory to CcO under physiological oxygen levels 
(Srinivasan and Avadhani, 2012). 
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2.5.4  Mitochondria Dysfunction and Oxidative Stress 
 
Mitochondria are the principal source of cellular reactive oxygen species (ROS).  
ROS, particularly superoxide anions, are formed invariably as by- products of the 
electron transport chain and other redox reactions in mitochondria through one-
electron reduction of molecular oxygen (O2).  Superoxide is then converted to 
hydrogen peroxide (H2O2) by superoxide dismutases (SODs), present both within the 
mitochondria and in the cytosol (Ferreira et al., 2010).  Depending on their type and 
rate of production, ROS have both physiological roles and pathological effects in the 
context of mitochondrial as well as whole cell function.  Excessive production of 
ROS and the associated cytotoxic effects are generally called oxidative stress 
(Kawamata and Manfredi, 2010; Waldbaum and Patel, 2010).  Peroxidation of 
membrane lipids, direct oxidation of amino acids, and oxidative cleavage of peptide 
bonds in proteins and DNA damage are some of the hallmarks of oxidative stress and 
are responsible for many of the disease symptoms.  Although several redox reactions 
take place in mitochondria, only a few of them have been shown to generate 
detectable oxygen free radicals.  While complexes I and III are the major sites of 
ROS formation, recent reports show that complex II can readily generate superoxide 
radicals in the absence of electron acceptors.  A volume of evidence suggests that 
CcO dysfunction is invariably associated with increased mitochondrial ROS 
production and cellular toxicity (Zambonin et al., 2010). 
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2.6  Axonal Transportation and Regeneration 
 
The unique morphology of neurons, highly polarized cells with extended axons and 
dendrites, makes them particularly dependent on active intracellular transport.  The 
transport of proteins, RNA, and organelles over long distances requires molecular 
motors that operate along the cellular cytoskeleton (Perlson et al., 2010; Stevens and 
Maier, 2008).  Two major roles for axonal transport are supply/clearance and long-
distance signalling.  Supply of newly synthesized proteins and lipids to the distal 
synapse maintains axonal activity, whereas misfolded and aggregated proteins are 
cleared from the axon by transport to the cell soma for efficient degradation.  Active 
transport of mitochondria also supplies local energy needs.  The second major role 
for active transport is the communication of intracellular signals from the distal axon 
to the soma, allowing the neuron to respond to changes in environment.  While 
defects in either supply or clearance can readily be predicted to be deleterious to the 
health of the neuron, there has been a growing appreciation that the propagation of 
stress-signaling along the axon could be a key neurodegenerative pathway leading to 
cell death (Yin et al., 2008). 
 
The proximal cause of cell death in affected neurons possibly is that inhibition of 
transport leads to defects in the localization or delivery of essential cargos.  For 
example, failure to deliver mitochondria to areas of need could induce cell death 
through energy deprivation. Or, disruption of lysosomal and/or autophagosome 
motility could lead to the toxic build-up of aggregated proteins or defective 
organelles (Magrane and Manfredi, 2009).  Another hypothesis is that the key defect 
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in axonal transport is not a disruption in bulk supply/clearance, but instead is an 
alteration in cell signalling (Amiri and Hollenbeck, 2008). 
 
Axons in the central nervous system (CNS) do not regrow after injury, whereas 
lesioned axons in the peripheral nervous system (PNS) regenerate.  After injury, the 
formation of a growth cone at the tip of a transected axon is a crucial step during 
subsequent axonal regeneration.  On the contrary, lesioned CNS axons form 
swellings termed “retraction bulbs” at the tip of their proximal stumps, which are 
oval structures and lack a regenerative response (De Vos et al., 2008).  Growth cones 
contain the machinery for movement and axonal extension consisting of a complex 
interplay of different intracellular events.  For example, mitochondria concentrate in 
the tip of the growing axon to provide energy necessary for axon formation.  Axon 
growth also depends on continuous membrane supply from the soma to support the 
surface expansion of the growing axon.  Notably, microtubules and their dynamic 
rearrangements are essential for axon outgrowth.  Retraction bulbs of injured CNS 
axons increase in size over time, whereas growth cones of injured PNS axons remain 
constant.  Retraction bulbs contain a disorganized microtubule network, whereas 
growth cones possess the typical bundling of microtubules.  Microtubules play a key 
role in axonal growth and guidance.  They form the backbone of the axonal shafts 
and core domain of growth cones, giving stability to those structures and enabling 
organelle transport (Mahad et al., 2009).  In addition, the dynamic microtubules 
protrude through the peripheral regions of growth cones, enabling axon elongation.  
Disruption of microtubules in growth cones transforms them into retraction bulb-like 
structures whose growth is inhibited.  Thus, the stability and organization of 
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microtubules define the fate of lesioned axonal stumps to become either advancing 
growth cones or non-growing retraction bulbs. 
 
2.7  Neurotrophic Factors 
 
Study by Yin et al. (2008) showed that motor nerves are superior to sensory nerves 
for promoting motoneuron survival and axonal regeneration after root avulsion.  This 
is partly caused by the higher expression of brain-derived neurotrophic factor 
(BDNF) and glial cell line-derived neurotrophic factor (GDNF) in motor nerves. 
 
Motoneurons require neurotrophic factors for survival during embryonic 
development and after injury in adult animals (Yin et al., 2008).  Neurotrophic 
factors for motoneurons are classified into families according to their structures.  
They include neurotrophins, cytokines, the transforming growth factor beta 
superfamily (TGF-β), and many others (Sendtner et al., 2009). 
 
BDNF and GDNF are well-known neurotrophic factors for motoneurons in the 
neurotrophin and transforming growth factor-β families, respectively.  The BDNF 
signals through tropomyosin receptor kinase B (TrkB) receptor, and/or low affinity 
nerve growth factor receptor (p75 neurotrophin receptor), whereas GDNF uses 
GDNF family receptors (GFR-α1 and c-ret).  They promote motoneuron survival 
both in vitro and in vivo.  Numerous studies have demonstrated that they also 
promote axonal regeneration (Yin et al., 2008). 
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2.8  Taxol 
 
Taxol (also known as Paclitaxel) has been approved by the U.S. Food and Drug 
Administration as an chemotherapeutic agent for the treatment of ovarian and breast 
cancer (Piccart et al., 2010; Rowinsky et al., 2009).  Currently, it is also being used 
to treat other tumors including non-small cell lung carcinoma and Kaposi‟s sarcoma.  
It is originally derived from the bark of the western yew tree called Taxus brevifolia.  
Compared to other oncogenic agents, the clinical development of taxol progressed 
slowly because of the small amounts of drug obtainable from the crude bark extract 
and its poor water solubility (Piccart et al., 2010). 
 
Taxol is a diterpene alkaloid and it‟s chemical name is 5β,20-Epoxy-
l,2α,4,7β,10β,13α-hexahydroxytax-l l-en-9-one 4,10-diacetate 2-benzoate 13-ester 
with (2R,3S)-N-benzoyl-3-phenylisoserine.  It is a white to off-white crystalline 
powder with the empirical formula C47H51NO14 and a molecular weight of 853.9.  It 
is highly lipophilic and melts at around 216-217° C (Sparreboom et al., 2008).  
Molecular structure of Taxol is shown in Figure 2.8. 
 
 
 
 
 
 
 
